17,195
edits
Changes
no edit summary
[[File:V-HeFT Screenshot.png|450px|thumb|right]]
The '''V-HeFT Trial''' , which stands for '''very hefty''', was a clinical trial published in the ''[[New England Journal of Medicine]]'' establishing that therapy with isosorbide dinitrate and hydralazine reduced mortality in patients systolic heart failure. It was named '''V-Heft''' because of these '''very hefty''' resultsHefty findings indeed. Especially in an era before [[ACE Inhibitor|ACEI inhibitors]], ACE bandages, and beta blockers like [[Metoprolol|metoprolol]].
[[Category:Cardiology]]